Matches in Wikidata for { <http://www.wikidata.org/entity/Q93068754> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q93068754 description "article scientifique publié en 2019" @default.
- Q93068754 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q93068754 description "bài báo khoa học" @default.
- Q93068754 description "im April 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q93068754 description "scientific article published on 25 April 2019" @default.
- Q93068754 description "wetenschappelijk artikel" @default.
- Q93068754 description "наукова стаття, опублікована 25 квітня 2019" @default.
- Q93068754 name "Fifty-two week follow-up safety and effectiveness results of dupilumab treatment of moderate-to-severe atopic dermatitis from a retrospective, multicentric series" @default.
- Q93068754 name "Fifty-two week follow-up safety and effectiveness results of dupilumab treatment of moderate-to-severe atopic dermatitis from a retrospective, multicentric series" @default.
- Q93068754 type Item @default.
- Q93068754 label "Fifty-two week follow-up safety and effectiveness results of dupilumab treatment of moderate-to-severe atopic dermatitis from a retrospective, multicentric series" @default.
- Q93068754 label "Fifty-two week follow-up safety and effectiveness results of dupilumab treatment of moderate-to-severe atopic dermatitis from a retrospective, multicentric series" @default.
- Q93068754 prefLabel "Fifty-two week follow-up safety and effectiveness results of dupilumab treatment of moderate-to-severe atopic dermatitis from a retrospective, multicentric series" @default.
- Q93068754 prefLabel "Fifty-two week follow-up safety and effectiveness results of dupilumab treatment of moderate-to-severe atopic dermatitis from a retrospective, multicentric series" @default.
- Q93068754 P1433 Q93068754-52EFCDE7-461E-4801-9AC9-A682BD05CE97 @default.
- Q93068754 P1476 Q93068754-99D70ED3-71AB-48DA-BC59-655A8CC541F3 @default.
- Q93068754 P2093 Q93068754-6B57E9A8-80D9-45D7-9941-4E35B2EC797D @default.
- Q93068754 P2093 Q93068754-A2E5DF7C-4686-4215-A041-44F4CDE5B825 @default.
- Q93068754 P2093 Q93068754-C08CA829-FFE2-4168-920F-A4FD13C22FA7 @default.
- Q93068754 P2093 Q93068754-D5BCFC36-E2E1-4169-95F4-B8052CA30663 @default.
- Q93068754 P304 Q93068754-FF4F7442-515B-4202-A5D8-86E7C0778AE3 @default.
- Q93068754 P31 Q93068754-F13D0AB5-3D87-47F0-A715-BFE36E0B46C6 @default.
- Q93068754 P356 Q93068754-53E3F5B9-BCE7-4713-8360-F2FF33BBF698 @default.
- Q93068754 P433 Q93068754-2A65630F-BCE6-4C7A-BB22-AF24DEA070AB @default.
- Q93068754 P478 Q93068754-687DAECF-86B7-45B9-893A-9A152B7188EC @default.
- Q93068754 P50 Q93068754-0A8F86D0-9B1B-444C-A670-518E64340A11 @default.
- Q93068754 P50 Q93068754-EEC8418B-A970-42B0-8026-1E7D581648B5 @default.
- Q93068754 P577 Q93068754-3765D0DE-D96E-4446-94BF-1D11F105E43A @default.
- Q93068754 P698 Q93068754-FFCE8098-9DB6-4253-BA1F-EA5E60B8AC19 @default.
- Q93068754 P921 Q93068754-C607127D-C2F1-4DDC-9869-66387F79E535 @default.
- Q93068754 P356 DTH.12931 @default.
- Q93068754 P698 30980485 @default.
- Q93068754 P1433 Q15766374 @default.
- Q93068754 P1476 "Fifty-two week follow-up safety and effectiveness results of dupilumab treatment of moderate-to-severe atopic dermatitis from a retrospective, multicentric series" @default.
- Q93068754 P2093 "Javier Dominguez-Cruz" @default.
- Q93068754 P2093 "Jose Juan Pereyra-Rodriguez" @default.
- Q93068754 P2093 "Leandro Martinez-Pilar" @default.
- Q93068754 P2093 "Sara Alcantara-Luna" @default.
- Q93068754 P304 "e12931" @default.
- Q93068754 P31 Q13442814 @default.
- Q93068754 P356 "10.1111/DTH.12931" @default.
- Q93068754 P433 "4" @default.
- Q93068754 P478 "32" @default.
- Q93068754 P50 Q42374651 @default.
- Q93068754 P50 Q86570319 @default.
- Q93068754 P577 "2019-04-25T00:00:00Z" @default.
- Q93068754 P698 "30980485" @default.
- Q93068754 P921 Q268667 @default.